13F Filings History of DINSMORE CAPITAL MANAGEMENT CO/NJ

Latest 13F report
Q3 2015 - 20 Oct 2015
Value $
$229,783,000
Signature - Title
Gary I. Levine - Chief Financial Officer
Location
Morristown, NJ
Summary
This page shows a list of all the recent 13F filings made by DINSMORE CAPITAL MANAGEMENT CO/NJ. Form 13F is required to be filed within 45 days of the end of a calendar quarter. DINSMORE CAPITAL MANAGEMENT CO/NJ reported 134 stock holdings with total value $229,783,000 as of Q3 2015. Top holdings included Gilead Sciences, Inc., AGNPRA, The Priceline Group Inc., AMSGP, and Molina Healthcare Inc..

Notify me when DINSMORE CAPITAL MANAGEMENT CO/NJ files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2015 134 $229,783,000 +$41,913,743 -$51,965,622 -$10,051,879 Gilead Sciences, Inc., AGNPRA, The Priceline Group Inc., AMSGP, Molina Healthcare Inc. 13F-HR 20 Oct 2015, 10:04
Q2 2015 147 $253,431,000 +$39,551,949 -$43,357,472 -$3,805,523 Gilead Sciences, Inc., Mylan Inc., Allergan plc, Incyte Corp., The Priceline Group Inc. 13F-HR 30 Jul 2015, 09:22
Q1 2015 146 $255,314,000 +$35,095,762 -$39,122,167 -$4,026,405 Gilead Sciences, Inc., Mylan Inc., Micron Technology, Inc., Equinix Inc., Hawaiian Holdings, Inc. 13F-HR 15 May 2015, 08:00
Q4 2014 147 $255,640,000 +$34,883,788 -$37,186,972 -$2,303,184 Gilead Sciences, Inc., Micron Technology, Inc., Hawaiian Holdings, Inc., UTXPRA, Mylan Inc. 13F-HR 13 Feb 2015, 11:24
Q3 2014 145 $254,247,000 +$30,419,462 -$29,700,076 +$719,386 Gilead Sciences, Inc., Micron Technology, Inc., UTXPRA, The Priceline Group Inc., BACPRL 13F-HR 14 Nov 2014, 16:34
Q2 2014 144 $260,238,000 +$30,852,896 -$29,748,315 +$1,104,581 Gilead Sciences, Inc., UTXPRA, Micron Technology, Inc., The Priceline Group Inc., Nuance Communications, Inc. 13F-HR 15 Aug 2014, 07:08
Q1 2014 138 $252,174,000 +$42,158,036 -$43,571,643 -$1,413,607 Gilead Sciences, Inc., UTXPRA, The Priceline Group Inc., Hawaiian Holdings, Inc., WFCPRL 13F-HR 14 May 2014, 09:02
Q4 2013 135 $246,683,000 $0 $0 $0 Gilead Sciences, Inc., UTXPRA, Gilead Sciences, Inc., Priceline.com Inc., WFCPRL 13F-HR 14 Feb 2014, 08:54